- Preview Available
- Scholarly Journal
Correction to: Exploratory Prognostic Biomarkers of Complement-Mediated Thrombotic Microangiopathy (CM-TMA) in Adults with Atypical Hemolytic Uremic Syndrome (aHUS): Analysis of a Phase III Study of Ravulizumab
Anonymous.
Molecular Diagnosis & Therapy; Auckland Vol. 27, Iss. 2, (Mar 2023): 281.
DOI:10.1007/s40291-023-00643-4
You might have access to more details...
Try and log in through your library or institution to see if they have access.
Title
Correction to: Exploratory Prognostic Biomarkers of Complement-Mediated Thrombotic Microangiopathy (CM-TMA) in Adults with Atypical Hemolytic Uremic Syndrome (aHUS): Analysis of a Phase III Study of Ravulizumab
Author
Anonymous
Pages
281
Section
CORRECTION
Publication year
2023
Publication date
Mar 2023
ISSN
11771062
e-ISSN
11792000
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2786945474
Copyright
Copyright Springer Nature B.V. Mar 2023





